Balance Sheet CME Group Inc.

Equities

CME

US12572Q1058

Financial & Commodity Market Operators

Market Closed - Nasdaq Other stock markets 00:00:00 13/05/2026 +04			5-day change	1st Jan Change
285.75 ^USD	+1.12%		-0.37%	+4.64%

02:15pm	S&P 500, Nasdaq futures rise ahead of key data, Trump's China visit	RE
01:07pm	UBS delays Fed rate cuts on inflation concerns, as jobs stay resilient	RE

7d2540e3d8eb72815022.cw5rHhMTh4oY4uHgQIDoVKWby2wRZ0p_wffsLUX_o58.ED0sLyp9wsZ71cyMdPbROdHVjyt1Vn0F9pKpZGiglepePClZUF3TvF2bgg

Published financial data: CME GROUP INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.34B	4.75B	5.25B	5.7B	6.08B
Other Revenues, Total	337M	255M	317M	422M	423M
Total Revenues	4.68B	5.01B	5.57B	6.12B	6.51B
Gross Profit	4.68B	5.01B	5.57B	6.12B	6.51B
Selling General & Admin Expenses, Total	1.48B	1.46B	1.57B	1.65B	1.75B
Depreciation & Amortization - (IS)	148M	135M	126M	115M	108M
Amortization of Goodwill and Intangible Assets - (IS)	238M	228M	227M	222M	223M
Other Operating Expenses	207M	187M	188M	201M	166M
Other Operating Expenses, Total	2.07B	2.01B	2.11B	2.18B	2.25B
Operating Income	2.6B	3B	3.46B	3.94B	4.26B
Interest Expense, Total	-167M	-163M	-159M	-161M	-173M
Interest And Investment Income	307M	2.2B	5.28B	4.08B	5.74B
Net Interest Expenses	140M	2.04B	5.12B	3.92B	5.56B
Income (Loss) On Equity Invest.	246M	301M	297M	351M	372M
Currency Exchange Gains (Loss)	40.7M	13.2M	-22.6M	-5.2M	-29.6M
Other Non Operating Income (Expenses)	-88.5M	-1.86B	-4.69B	-3.67B	-4.85B
EBT, Excl. Unusual Items	2.94B	3.49B	4.15B	4.53B	5.31B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	9.2M	16.9M
Gain (Loss) On Sale Of Assets	431M	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	3.37B	3.49B	4.15B	4.54B	5.33B
Income Tax Expense	737M	799M	927M	1.02B	1.26B
Earnings From Continuing Operations	2.64B	2.69B	3.23B	3.53B	4.07B
Net Income to Company	2.64B	2.69B	3.23B	3.53B	4.07B
Minority Interest	-500K	-	-	-	-
Net Income - (IS)	2.64B	2.69B	3.23B	3.53B	4.07B
Preferred Dividend and Other Adjustments	19.3M	33.8M	40.6M	44.3M	51.2M
Net Income to Common Incl Extra Items	2.62B	2.66B	3.19B	3.48B	4.02B
Net Income to Common Excl. Extra Items	2.62B	2.66B	3.19B	3.48B	4.02B
Per Share Items
Net EPS - Basic	7.3	7.41	8.87	9.69	11.18
Basic EPS - Continuing Operations	7.3	7.41	8.87	9.69	11.18
Basic Weighted Average Shares Outstanding	358M	359M	359M	359M	360M
Net EPS - Diluted	7.29	7.4	8.86	9.67	11.16
Diluted EPS - Continuing Operations	7.29	7.4	8.86	9.67	11.16
Diluted Weighted Average Shares Outstanding	359M	359M	360M	360M	360M
Normalized Basic EPS	5.13	6.08	7.23	7.88	9.23
Normalized Diluted EPS	5.12	6.07	7.22	7.87	9.22
Dividend Per Share	3.6	4	4.4	4.6	5
Payout Ratio	83.04	97.86	100.29	101.66	96.58
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	2.99B	3.37B	3.81B	4.27B	4.59B
EBITA	2.84B	3.23B	3.68B	4.16B	4.48B
EBIT	2.6B	3B	3.46B	3.94B	4.26B
EBITDAR	3.04B	3.41B	3.86B	4.32B	4.62B
Total Revenues (As Reported)	4.69B	5.02B	5.58B	6.13B	6.52B
Effective Tax Rate - (Ratio)	21.84	22.9	22.33	22.36	23.61
Current Domestic Taxes	683M	798M	958M	1.03B	1.22B
Current Foreign Taxes	19M	24.9M	44.9M	52.3M	48.1M
Total Current Taxes	702M	822M	1B	1.08B	1.26B
Deferred Domestic Taxes	6M	-23.6M	-11.9M	-66.6M	-5.6M
Deferred Foreign Taxes	28.8M	400K	-63.1M	200K	-500K
Total Deferred Taxes	34.8M	-23.2M	-75M	-66.4M	-6.1M
Normalized Net Income	1.84B	2.18B	2.6B	2.83B	3.32B
Interest on Long-Term Debt	3.1M	2.8M	2.5M	2.2M	1.9M
Non-Cash Pension Expense	-6.5M	-8.9M	-2.8M	-4.9M	-4.3M
Supplemental Operating Expense Items
General and Administrative Expenses	581M	646M	686M	744M	805M
Research And Development Expense From Footnotes	193M	189M	219M	256M	283M
Net Rental Expense, Total	53.5M	46.7M	45.7M	42M	25.2M
Imputed Operating Lease Interest Expense	17.64M	15.25M	14.88M	14.03M	9.23M
Imputed Operating Lease Depreciation	35.86M	31.45M	30.82M	27.97M	15.97M
Stock-Based Comp., SG&A Exp. (Total)	76.4M	84.8M	83.7M	90.4M	95.6M
Total Stock-Based Compensation	76.4M	84.8M	83.7M	90.4M	95.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.83B	2.72B	2.91B	2.89B	4.42B
Short Term Investments	115M	96M	112M	113M	125M
Total Cash And Short Term Investments	2.95B	2.82B	3.02B	3.01B	4.54B
Accounts Receivable, Total	434M	483M	536M	573M	639M
Total Receivables	434M	483M	536M	573M	639M
Restricted Cash	4.8M	4.9M	5.2M	6.3M	6.5M
Other Current Assets, Total	158B	136B	91.33B	99.45B	160B
Total Current Assets	162B	139B	94.89B	103B	165B
Gross Property Plant And Equipment	1.97B	1.98B	1.68B	1.7B	1.62B
Accumulated Depreciation	-1.04B	-1.15B	-933M	-1.02B	-1.01B
Net Property Plant And Equipment	931M	838M	744M	672M	618M
Long-term Investments	2.44B	2.76B	67.8M	2.58B	2.15B
Goodwill	10.53B	10.48B	10.5B	10.49B	10.51B
Other Intangibles, Total	20.71B	20.44B	20.23B	20B	19.79B
Other Long-Term Assets, Total	413M	574M	3.28B	677M	-
Total Assets	197B	174B	130B	137B	198B
Liabilities
Accounts Payable, Total	48.8M	121M	90.6M	79.9M	71.8M
Short-term Borrowings	749M	16M	-	-	-
Current Portion of Long-Term Debt	-	-	-	750M	-
Current Portion of Leases	55.2M	58.1M	55.1M	53.4M	55.8M
Unearned Revenue Current, Total	15.2M	12.7M	13.2M	-	-
Other Current Liabilities	160B	137B	93.26B	101B	160B
Total Current Liabilities	160B	138B	93.42B	102B	160B
Long-Term Debt	2.7B	3.42B	3.43B	2.68B	3.42B
Long-Term Leases	525M	451M	403M	340M	279M
Deferred Tax Liability Non Current	5.39B	5.36B	5.33B	5.25B	5.24B
Other Non Current Liabilities	371M	375M	395M	381M	456M
Total Liabilities	169B	147B	103B	111B	170B
Common Stock, Total	3.6M	3.6M	3.6M	3.6M	3.6M
Additional Paid In Capital	22.19B	22.26B	22.33B	22.4B	22.21B
Retained Earnings	5.15B	4.75B	4.46B	4.19B	6.43B
Comprehensive Income and Other	53.5M	-133M	-55.6M	-106M	81.9M
Total Common Equity	27.4B	26.88B	26.74B	26.49B	28.73B
Minority Interest	-	-	-	-	-
Total Equity	27.4B	26.88B	26.74B	26.49B	28.73B
Total Liabilities And Equity	197B	174B	130B	137B	198B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	359M	360M	360M	360M	359M
ECS Total Common Shares Outstanding	359M	359M	359M	360M	359M
Book Value / Share	76.41	74.89	74.43	73.66	80.03
Tangible Book Value	-3.84B	-4.05B	-3.98B	-4B	-1.57B
Tangible Book Value Per Share	-10.7	-11.28	-11.09	-11.11	-4.38
Total Debt	4.03B	3.95B	3.88B	3.82B	3.76B
Net Debt	1.08B	1.13B	860M	816M	-785M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-16.3M	-15.3M	700K	-3.5M	-5.4M
Debt Equivalent Oper. Leases	428M	374M	366M	336M	202M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	2.44B	2.76B	67.8M	2.57B	2.14B
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	-	-	-	-	-
Buildings, Total	132M	132M	131M	131M	131M
Machinery, Total	519M	551M	413M	433M	375M
Full Time Employees	3.48K	3.46K	3.56K	3.76K	3.88K
Accumulated Allowance for Doubtful Accounts (Supple)	5.6M	8.1M	7.1M	9M	10M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.64B	2.69B	3.23B	3.53B	4.07B
Depreciation & Amortization - CF	148M	135M	126M	115M	108M
Amortization of Goodwill and Intangible Assets - (CF)	238M	228M	227M	222M	223M
Depreciation & Amortization, Total	385M	363M	353M	337M	331M
(Gain) Loss From Sale Of Asset	-30.4M	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-117M	-4.8M	-72.1M	-3.6M	-353M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-425M	-	-	-	-
Stock-Based Compensation (CF)	75.2M	84.3M	82.9M	89.5M	94.8M
Other Operating Activities, Total	39.7M	18.1M	-40.6M	-69.4M	32.3M
Change In Accounts Receivable	-45.7M	-51.1M	-51.5M	-39.4M	-67.1M
Change In Accounts Payable	-18.6M	72.5M	-30.8M	-10.7M	-8.1M
Change In Income Taxes	-120M	-148M	-77.1M	-117M	91.1M
Change in Other Net Operating Assets	23M	31.2M	64.2M	-21.1M	83.8M
Cash from Operations	2.4B	3.06B	3.45B	3.69B	4.28B
Capital Expenditure	-127M	-89.7M	-76.4M	-94M	-83.5M
Cash Acquisitions	-52.9M	-	-	-	-
Sale (Purchase) of Real Estate properties	39.3M	-	-	-	-
Investment in Marketable and Equity Securities, Total	199M	-400M	97.3M	11.4M	1.58B
Cash from Investing	58.4M	-490M	20.9M	-82.6M	1.5B
Long-Term Debt Issued, Total	-	741M	-	-	741M
Total Debt Issued	-	741M	-	-	741M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-756M	-16.4M	-	-750M
Total Debt Repaid	-	-756M	-16.4M	-	-750M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-31.7M	-24.8M	-21.4M	-33M	-300M
Issuance of Preferred Stock	965M	-	-	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-2.19B	-2.63B	-3.24B	-3.58B	-3.93B
Common & Preferred Stock Dividends Paid	-2.19B	-2.63B	-3.24B	-3.58B	-3.93B
Other Financing Activities, Total	71.16B	-22.71B	-45.07B	8.69B	60.75B
Cash from Financing	69.91B	-25.38B	-48.34B	5.08B	56.51B
Net Change in Cash	72.37B	-22.82B	-44.86B	8.68B	62.29B
Supplemental Items
Cash Interest Paid	133M	133M	130M	130M	136M
Cash Income Tax Paid (Refund)	755M	973M	1.11B	1.2B	1.16B
Levered Free Cash Flow	2.04B	2.7B	2.57B	2.68B	837M
Unlevered Free Cash Flow	2.15B	2.8B	2.67B	2.78B	946M
Change In Net Working Capital	-186M	-569M	-144M	12.5M	2.06B
Net Debt Issued / Repaid	-	-15.2M	-16.4M	-	-9.4M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.01	1.01	1.42	1.84	1.58
Return on Total Capital	5.26	6.03	7.03	8.08	8.48
Return On Equity %	9.81	9.92	12.03	13.25	14.75
Return on Common Equity	9.74	9.79	11.88	13.08	14.56
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	31.67	29.08	28.19	26.89	26.91
EBITDA Margin %	63.9	67.19	68.43	69.82	70.54
EBITA Margin %	60.74	64.49	66.17	67.94	68.89
EBIT Margin %	55.66	59.95	62.1	64.32	65.46
Income From Continuing Operations Margin %	56.35	53.73	57.93	57.61	62.58
Net Income Margin %	56.34	53.73	57.93	57.61	62.58
Net Avail. For Common Margin %	55.93	53.05	57.2	56.88	61.8
Normalized Net Income Margin	39.29	43.55	46.61	46.28	51.04
Levered Free Cash Flow Margin	43.68	53.94	46.07	43.8	12.87
Unlevered Free Cash Flow Margin	45.91	55.98	47.86	45.44	14.53
Asset Turnover
Asset Turnover	0.03	0.03	0.04	0.05	0.04
Fixed Assets Turnover	4.7	5.66	7.04	8.65	10.09
Receivables Turnover (Average Receivables)	9.69	10.36	10.31	10.28	10.04
Short Term Liquidity
Current Ratio	1.01	1.01	1.02	1.01	1.03
Quick Ratio	0.02	0.02	0.04	0.03	0.03
Operating Cash Flow to Current Liabilities	0.01	0.02	0.04	0.04	0.03
Days Sales Outstanding (Average Receivables)	37.65	35.23	35.4	35.6	36.36
Long Term Solvency
Total Debt/Equity	14.69	14.69	14.53	14.43	13.08
Total Debt / Total Capital	12.81	12.81	12.68	12.61	11.57
LT Debt/Equity	11.76	14.41	14.32	11.4	12.88
Long-Term Debt / Total Capital	10.25	12.57	12.5	9.96	11.39
Total Liabilities / Total Assets	86.08	84.57	79.39	80.73	85.52
EBIT / Interest Expense	15.61	18.46	21.7	24.47	24.56
EBITDA / Interest Expense	18.23	20.97	24.19	26.82	26.62
(EBITDA - Capex) / Interest Expense	17.47	20.42	23.72	26.24	26.13
Total Debt / EBITDA	1.32	1.16	1.01	0.89	0.81
Net Debt / EBITDA	0.35	0.33	0.22	0.19	-0.17
Total Debt / (EBITDA - Capex)	1.38	1.19	1.03	0.91	0.83
Net Debt / (EBITDA - Capex)	0.37	0.34	0.23	0.19	-0.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.92	9.74	11.19	9.9	6.32
Gross Profit, 1 Yr. Growth %	-3.92	9.74	11.19	9.9	6.32
EBITDA, 1 Yr. Growth %	-4.71	17.06	13.24	12.14	7.41
EBITA, 1 Yr. Growth %	-4.77	18.46	14.07	12.85	7.79
EBIT, 1 Yr. Growth %	-2.58	20.62	15.17	13.83	8.19
Earnings From Cont. Operations, 1 Yr. Growth %	25.19	2.05	19.89	9.29	15.5
Net Income, 1 Yr. Growth %	25.23	2.07	19.89	9.29	15.5
Normalized Net Income, 1 Yr. Growth %	7.11	23.48	19	9.11	17.24
Diluted EPS Before Extra, 1 Yr. Growth %	24.19	1.51	19.73	9.14	15.41
Accounts Receivable, 1 Yr. Growth %	-5.81	11.21	10.84	7	11.53
Net Property, Plant and Equip., 1 Yr. Growth %	-12.05	-10.01	-11.14	-9.78	-7.89
Total Assets, 1 Yr. Growth %	57.85	-11.49	-25.53	5.97	44.36
Tangible Book Value, 1 Yr. Growth %	-41.16	5.55	-1.63	0.35	-60.66
Common Equity, 1 Yr. Growth %	4.1	-1.9	-0.52	-0.94	8.46
Cash From Operations, 1 Yr. Growth %	-11.53	27.21	13.02	6.85	15.89
Capital Expenditures, 1 Yr. Growth %	-35.6	-29.48	-14.83	23.04	-11.17
Levered Free Cash Flow, 1 Yr. Growth %	2.87	37.01	-5.04	4.47	-68.77
Unlevered Free Cash Flow, 1 Yr. Growth %	2.75	35.02	-4.93	4.34	-66
Dividend Per Share, 1 Yr. Growth %	5.88	11.11	10	4.55	8.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.96	1.27	8.97	10.42	8
Gross Profit, 2 Yr. CAGR %	-1.96	1.27	8.97	10.42	8
EBITDA, 2 Yr. CAGR %	-2.25	3.56	12.9	12.69	9.75
EBITA, 2 Yr. CAGR %	-2.19	4.04	13.87	13.46	10.29
EBIT, 2 Yr. CAGR %	-0.98	5.98	15.23	14.5	10.98
Earnings From Cont. Operations, 2 Yr. CAGR %	11.64	13.03	10.61	14.46	12.35
Net Income, 2 Yr. CAGR %	11.61	13.06	10.62	14.46	12.35
Normalized Net Income, 2 Yr. CAGR %	3.39	12.73	18.22	13.95	13.1
Diluted EPS Before Extra, 2 Yr. CAGR %	11.06	12.28	10.24	14.31	12.23
Accounts Receivable, 2 Yr. CAGR %	-6.01	2.35	11.03	8.91	9.24
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.23	-11.04	-10.58	-10.46	-8.84
Total Assets, 2 Yr. CAGR %	61.75	18.2	-18.81	-11.17	23.68
Tangible Book Value, 2 Yr. CAGR %	-25.47	-21.19	1.9	-0.64	-37.17
Common Equity, 2 Yr. CAGR %	2.4	1.06	-1.21	-0.73	3.66
Cash From Operations, 2 Yr. CAGR %	-5.19	6.08	19.9	9.89	11.28
Capital Expenditures, 2 Yr. CAGR %	-28.03	-32.61	-22.5	2.37	4.54
Levered Free Cash Flow, 2 Yr. CAGR %	-2.33	16.61	12.04	-0.4	-42.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	-2.37	15.8	11.38	-0.4	-40.44
Dividend Per Share, 2 Yr. CAGR %	9.54	8.47	10.55	7.24	6.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.78	0.96	4.48	9.28	9.04
Gross Profit, 3 Yr. CAGR %	2.78	0.96	4.48	9.28	9.04
EBITDA, 3 Yr. CAGR %	0.68	2.45	6.69	12.64	10.9
EBITA, 3 Yr. CAGR %	0.36	2.83	7.28	13.53	11.54
EBIT, 3 Yr. CAGR %	-0.96	4.17	8.96	14.76	12.36
Earnings From Cont. Operations, 3 Yr. CAGR %	10.32	8.35	15.27	10.17	14.81
Net Income, 3 Yr. CAGR %	10.35	8.33	15.29	10.17	14.81
Normalized Net Income, 3 Yr. CAGR %	1.96	8.25	14.78	15.1	15.04
Diluted EPS Before Extra, 3 Yr. CAGR %	8.48	7.78	14.71	9.88	14.68
Accounts Receivable, 3 Yr. CAGR %	-7.74	-0.59	5.1	9.67	9.77
Net Property, Plant and Equip., 3 Yr. CAGR %	27.54	-7.51	-11.07	-10.31	-9.61
Total Assets, 3 Yr. CAGR %	36.44	32.3	1.33	-11.27	4.44
Tangible Book Value, 3 Yr. CAGR %	-20.25	-16.31	-15.15	1.38	-27.04
Common Equity, 3 Yr. CAGR %	1.87	0.95	0.53	-1.12	2.24
Cash From Operations, 3 Yr. CAGR %	-0.53	4.57	8.35	15.38	11.86
Capital Expenditures, 3 Yr. CAGR %	2.91	-28.52	-27.14	-9.59	-2.36
Levered Free Cash Flow, 3 Yr. CAGR %	16.14	8.04	8.89	9.46	-32.33
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.25	7.54	8.43	8.99	-30.39
Dividend Per Share, 3 Yr. CAGR %	8.74	10.06	8.97	8.51	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.41	6.56	5.26	4.68	5.91
Gross Profit, 5 Yr. CAGR %	5.41	6.56	5.26	4.68	5.91
EBITDA, 5 Yr. CAGR %	4.08	6.04	5.4	6.43	7.9
EBITA, 5 Yr. CAGR %	4.15	6.15	5.56	6.96	8.47
EBIT, 5 Yr. CAGR %	3.22	5.47	5.22	8.19	9.76
Earnings From Cont. Operations, 5 Yr. CAGR %	11.44	-7.91	10.44	10.75	14.09
Net Income, 5 Yr. CAGR %	11.44	-7.91	10.46	10.75	14.11
Normalized Net Income, 5 Yr. CAGR %	5.16	6.68	8.4	10.49	14.11
Diluted EPS Before Extra, 5 Yr. CAGR %	9.98	-9.12	9.18	10.35	13.71
Accounts Receivable, 5 Yr. CAGR %	3.58	6.08	-0.65	3.11	6.74
Net Property, Plant and Equip., 5 Yr. CAGR %	16.96	15.95	10.65	-8.7	-10.19
Total Assets, 5 Yr. CAGR %	23.19	18.11	10.86	12.81	9.74
Tangible Book Value, 5 Yr. CAGR %	-10.94	-2.85	-12.03	-10.36	-24.76
Common Equity, 5 Yr. CAGR %	6.14	3.7	0.62	0.27	1.77
Cash From Operations, 5 Yr. CAGR %	6.76	11.78	7.19	6.67	9.51
Capital Expenditures, 5 Yr. CAGR %	6.74	1.84	-8.12	-17.48	-15.82
Levered Free Cash Flow, 5 Yr. CAGR %	3.84	13.35	14.48	4.58	-15.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.95	13.07	13.69	4.29	-14.68
Dividend Per Share, 5 Yr. CAGR %	8.45	8.67	9.46	8.92	8.02